Boxer Capital Management »

Neumora Therapeutics shares owned by Boxer Capital Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Boxer Capital Management from 13F filings

Historical chart of Boxer Capital Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Boxer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Boxer Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 2.0M 1.70

More positions owned by Boxer Capital Management

Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv SHS (QURE)
Kodiak Sciences (KOD)
Kymera Therapeutics (KYMR)
Definium Therapeutics Com Shs (DFTX)
Replimune Group (REPL)
Celcuity (CELC)
Q32 Bio (QTTB)
Capricor Therapeutics Com New (CAPR)
Precigen (PGEN)
Corcept Therapeutics Incorporated (CORT)
Surrozen Com New (SRZN)
Protagonist Therapeutics (PTGX)

View all positions for Boxer Capital Management

Top funds holding Neumora Therapeutics

Siren
BlackRock
Softbank Group Corp
Tudor Investment Corporation
Vanguard Capital Management
MIC Capital Management UK
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Geode Capital Management
ICONIQ Capital
Two Sigma Investments
OrbiMed Advisors
Lunate Capital
Boxer Capital Management
Johnson & Johnson

View all funds holding Neumora Therapeutics